Market Leadership StudyKIK is a renowned global leader in patient recruitment and retention technology, with a proven track record of connecting over 3.1 million patients to clinical studies, highlighting its established presence and potential for expansion within the research services industry.

Strategic Acquisition Being acquired by Syneos Health in 2021 positions StudyKIK as part of a larger healthcare ecosystem, creating cross-selling opportunities and enhanced credibility to attract new clients seeking integrated clinical trial solutions and innovative patient engagement tools.

Innovation Recognition The company's recent receipt of the Participation Engagement Award for its Oncology Study App demonstrates its commitment to innovative communication strategies, making it an attractive partner for sponsors prioritizing advanced patient engagement and retention technologies.

Service Diversification StudyKIK offers a comprehensive platform that includes patient recruitment, telemedicine, eConsent, and mobile retention applications, providing a one-stop solution that appeals to research organizations seeking streamlined, technology-driven trial management.

Growth Potential With an annual revenue estimated between $25 million and $50 million and a workforce of up to 200 employees, StudyKIK exhibits strong financial health and scalability, representing promising sales opportunities for partners offering complementary services or expanding into the clinical research market.